News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
196,231 Results
Type
Article (14667)
Company Profile (31)
Press Release (181533)
Section
Business (55560)
Career Advice (687)
Deals (9855)
Drug Delivery (31)
Drug Development (29617)
Employer Resources (71)
FDA (5011)
Job Trends (4329)
News (100821)
Policy (8534)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1328)
Academic (1)
Adcomms (7)
Allergies (32)
Alliances (16183)
ALS (37)
Alzheimer's disease (453)
Antibody-drug conjugate (ADC) (22)
Approvals (5022)
Artificial intelligence (62)
Autoimmune disease (7)
Automation (3)
Bankruptcy (80)
Best Places to Work (3543)
BIOSECURE Act (7)
Biosimilars (33)
Biotechnology (17)
Bladder cancer (20)
Brain cancer (8)
Breast cancer (76)
Cancer (561)
Cardiovascular disease (59)
Career advice (576)
Career pathing (15)
CAR-T (48)
Cell therapy (120)
Cervical cancer (9)
Clinical research (24901)
Collaboration (205)
Compensation (13)
Complete response letters (2)
COVID-19 (1229)
CRISPR (12)
C-suite (57)
Cystic fibrosis (20)
Data (705)
Decentralized trials (1)
Denatured (9)
Depression (9)
Diabetes (94)
Diagnostics (1933)
Digital health (3)
Diversity (5)
Diversity, equity & inclusion (28)
Drug discovery (44)
Drug pricing (38)
Drug shortages (16)
Duchenne muscular dystrophy (31)
Earnings (15578)
Editorial (14)
Employer branding (6)
Employer resources (64)
Events (23240)
Executive appointments (199)
FDA (5340)
Featured Employer (11)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (230)
Gene editing (22)
Generative AI (7)
Gene therapy (85)
GLP-1 (265)
Government (1373)
Grass and pollen (1)
Guidances (10)
Healthcare (5807)
Huntington's disease (6)
IgA nephropathy (8)
Immunology and inflammation (30)
Indications (6)
Infectious disease (1283)
Inflammatory bowel disease (54)
Inflation Reduction Act (4)
Influenza (20)
Intellectual property (19)
Interviews (112)
IPO (3721)
IRA (19)
Job creations (919)
Job search strategy (512)
Kidney cancer (2)
Labor market (6)
Layoffs (88)
Leadership (7)
Legal (1631)
Liver cancer (23)
Lung cancer (63)
Lymphoma (39)
Machine learning (1)
Management (22)
Manufacturing (74)
MASH (33)
Medical device (3546)
Medtech (3548)
Mergers & acquisitions (6271)
Metabolic disorders (213)
Multiple sclerosis (35)
NASH (15)
Neurodegenerative disease (23)
Neuropsychiatric disorders (3)
Neuroscience (625)
NextGen: Class of 2025 (2176)
Non-profit (1866)
Northern California (524)
Obesity (96)
Opinion (53)
Ovarian cancer (15)
Pain (31)
Pancreatic cancer (18)
Parkinson's disease (50)
Partnered (10)
Patents (34)
Patient recruitment (33)
Peanut (18)
People (19889)
Pharmaceutical (13)
Pharmacy benefit managers (9)
Phase I (5779)
Phase II (10741)
Phase III (9924)
Pipeline (280)
Podcasts (12)
Policy (49)
Postmarket research (1169)
Preclinical (2206)
Press Release (48)
Prostate cancer (33)
Psychedelics (9)
Radiopharmaceuticals (65)
Rare diseases (101)
Real estate (1675)
Recruiting (24)
Regulatory (6173)
Reports (15)
Research institute (1151)
Resumes & cover letters (90)
Rett syndrome (1)
RSV (18)
Schizophrenia (21)
Series A (48)
Series B (31)
Service/supplier (3)
Sickle cell disease (12)
Southern California (500)
Special edition (2)
Spinal muscular atrophy (70)
Sponsored (4)
Startups (1363)
Stomach cancer (4)
Supply chain (15)
The Weekly (3)
United States (5133)
Vaccines (306)
Venture capitalists (9)
Webinars (6)
Weight loss (66)
Women's health (18)
Worklife (6)
Date
Today (38)
Last 7 days (218)
Last 30 days (767)
Last 365 days (8967)
2025 (2227)
2024 (9291)
2023 (10673)
2022 (14468)
2021 (16167)
2020 (15900)
2019 (14939)
2018 (11613)
2017 (10776)
2016 (10323)
2015 (12173)
2014 (8381)
2013 (6750)
2012 (7010)
2011 (7525)
2010 (6585)
Location
Africa (281)
Alabama (9)
Alaska (4)
Arizona (41)
Arkansas (2)
Asia (13593)
Australia (2589)
California (1242)
Canada (404)
China (151)
Colorado (55)
Connecticut (52)
Delaware (35)
Europe (35359)
Florida (169)
Georgia (109)
Idaho (15)
Illinois (144)
India (9)
Indiana (81)
Iowa (2)
Japan (63)
Kansas (34)
Kentucky (7)
Louisiana (4)
Maine (12)
Maryland (224)
Massachusetts (854)
Michigan (41)
Minnesota (128)
Missouri (29)
Montana (7)
Nebraska (6)
Nevada (16)
New Hampshire (11)
New Jersey (459)
New Mexico (8)
New York (492)
North Carolina (194)
North Dakota (1)
Northern California (524)
Ohio (47)
Oklahoma (3)
Oregon (5)
Pennsylvania (315)
Puerto Rico (3)
Rhode Island (11)
South America (406)
South Carolina (8)
Southern California (500)
Tennessee (18)
Texas (163)
Utah (20)
Virginia (32)
Washington D.C. (10)
Washington State (162)
West Virginia (1)
Wisconsin (10)
196,231 Results for "enigma biomedical group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enigma Biomedical USA, Inc. Announces Candidate Selection of Novel 4R Tau PET Imaging Biomarkers
March 21, 2025
·
2 min read
Press Releases
Enigma Biomedical USA Announces Formation of Scientific Advisory Board
December 3, 2024
·
3 min read
Press Releases
Neuraly and Enigma Biomedical USA announce a Research License and Commercialization Option Agreement for PET Imaging Biomarker, PMI04
January 17, 2025
·
4 min read
Business
Enigma Biomedical Group - USA Signs License Agreement with AbbVie for Novel 4R Tau PET Imaging Biomarkers
Enigma Biomedical Group - USA (EBG-USA) today announced it has signed an exclusive license and option agreement with AbbVie for the development and potential commercialization of AbbVie’s next-generation F18 PET imaging biomarkers to assess the presence of four-repeat (4R) tau protein in patients with suspected neurodegenerative disease.
January 18, 2024
·
2 min read
Press Releases
Enigma Biomedical USA and the University of Wisconsin–Madison announce Formation of a Partnership to Advance Development of Next-Generation Imaging and Fluid Biomarkers for Improved Understanding and Management of Neurodegenerative Diseases
January 16, 2025
·
3 min read
Business
Enigma Biomedical - USA Announces Appointment of Hartmuth Kolb, PhD as Chief Scientific Officer
Enigma Biomedical USA announced the appointment of Hartmuth Kolb, PhD as Chief Science Officer. Dr. Kolb’s passion for innovation and scientific rigor has driven his extensive career and broad recognition.
February 13, 2024
·
2 min read
Press Releases
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs
October 31, 2024
·
8 min read
Press Releases
European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
December 20, 2024
·
4 min read
Press Releases
European Wellness Biomedical Group, Headed by Prof. Mike Chan, Release New Study on Bioregenerative Blueprint for Athletic Longevity
November 26, 2024
·
6 min read
Press Releases
European Wellness Biomedical Group Unveils State-of-the-Art Premier Centre in Kota Kinabalu, Sabah
October 10, 2024
·
7 min read
1 of 19,624
Next
